USP14 Gene Expression Combined with Clinical Factors for Predicting Symptomatic Recurrence After Surgery for Deep Infiltrating Endometriosis: A Retrospective Cohort Study
Observational
OA: closed
public-domain-us
Abstract
Deep infiltrating endometriosis (DIE) exhibits high postoperative recurrence rates, yet current prediction models lack molecular insights for precise risk stratification. This study aimed to determine whether ubiquitin-specific protease 14 (USP14) mRNA expression in DIE lesions is independently associated with postoperative symptomatic recurrence and to construct a combined clinico-molecular predictive model with enhanced accuracy. A retrospective cohort of 235 surgically treated DIE patients was analyzed. The least absolute shrinkage and selection operator (LASSO) was applied for variable selection. Subsequently, Cox multivariate regression was performed to identify independent risk factors. Multivariate Cox regression revealed that high USP14 expression (HR = 1.656; 95% CI: 1.307-2.099; P < 0.001), adhesion (HR = 1.861; 95%CI: 1.013-3.419; P = 0.045), bowel lesions (HR = 2.168; 95%CI: 1.278-3.679; P = 0.004), and adenomyosis (HR = 2.645; 95%CI: 1.568-4.462; P < 0.001) were independent risk factors, while GnRH-a therapy ≥ 6 months (HR = 0.126; 95%CI: 0.044-0.363; P < 0.001) and postoperative pregnancy (HR = 0.402; 95%CI: 0.200-0.807; P = 0.010) were independent protectors. The combined model integrating USP14 with these clinical factors achieved a superior C-index of 0.896 (95%CI: 0.879-0.912), outperforming the clinical-only model [C-index: 0.870 (95%CI: 0.849-0.892)]. Bootstrap internal validation (2,000 resamples) yielded optimism-corrected C-indices of 0.888 and 0.863 for the combined and clinical-only models, respectively. The integrated discrimination improvement (IDI) was 0.044 (95% CI: -0.013 to 0.11; P = 0.047); as the bootstrap confidence interval narrowly included zero, this result was interpreted as borderline, while complementary analyses supported the incremental value of USP14 (continuous net reclassification improvement: 0.655, P = 0.026; bootstrap-validated ΔC-index: 0.020, 95% CI: 0.002-0.048, P = 0.033). In conclusion, high USP14 expression is independently associated with postoperative symptomatic recurrence in DIE, and its incorporation into a combined prediction model provides a modest but consistent improvement in prognostic accuracy; as a retrospectively developed, internally validated model, it is hypothesis-generating and requires external, multi-center validation before clinical implementation.
My notes (saved in your browser only)
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (34)
- Analysis of clinical characteristics, diagnosis, treatment, and postoperative outcomes in deep infiltrating endometriosis: a retrospective study via openalex
- Clinical challenges and therapeutic strategies in women with endometriosis, deep infiltrating endometriosis, and/or adenomyosis undergoing assisted reproductive technologies: a narrative review via openalex
- Deep Infiltrating Endometriosis in Adolescence: Early Diagnosis and Possible Prevention of Disease Progression via openalex
- Diagnostic utility of Synuclein gamma (SNCG) and b-cell Lymphoma 6 (BCL6) as potential non-invasive dual biomarkers for endometriosis via openalex
- Dienogest in conjunction with GnRH-a for postoperative management of endometriosis via openalex
- Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial via openalex
- Effects of postoperative medical treatment and expectant treatment on dysmenorrhea after conservative laparoscopic surgery for deep-infiltrating endometriosis accompanied by dysmenorrhea via openalex
- Enhanced recovery after posterior deep infiltrating endometriosis surgery: a national study via openalex
- Identification and verification of diagnostic biomarkers for deep infiltrating endometriosis based on machine learning algorithms via openalex
- Inflammatory Cytokine Signatures Are Associated With Disease Burden and Comorbidity of Episodic Migraine and Endometriosis via openalex
- Laparoscopic surgery with urinary tract reconstruction and bowel endometriosis resection for deep infiltrating endometriosis via openalex
- Multi-ancestry genome-wide association and integrated multi-omics analyses of endometriosis and its clinical manifestations via openalex
- Neutrophil to lymphocytes ratio in deep infiltrating endometriosis as a new toll for clinical management via openalex
- New Insights into Genetics of Endometriosis-A Comprehensive Literature Review via openalex
- Nomogram predicting the likelihood of live-birth rate after surgery for deep infiltrating endometriosis without bowel involvement in women who wish to conceive: A retrospective study via openalex
- Plasma proteomic profiles of pain subtypes in adolescents and young adults with endometriosis via openalex
- Predicting disease recurrence in patients with endometriosis: an observational study via openalex
- Proteomics approach to discovering non-invasive diagnostic biomarkers and understanding the pathogenesis of endometriosis: a systematic review and meta-analysis via openalex
- Risk factors for recurrence of deep infiltrating endometriosis after surgical treatment via openalex
- Risk of endometriosis progression in infertile women trying to conceive naturally or using IVF via openalex
- Robotic assisted laparoscopy for deep infiltrating endometriosis via openalex
- W4405753240 via openalex
- W4410392422 via openalex
- W4328135802 via openalex
- W4413097660 via openalex
- W4414321945 via openalex
- W4414703924 via openalex
- W4233026002 via openalex
- W2065390631 via openalex
- W4415608479 via openalex
- W56226576 via openalex
- W1600041372 via openalex
- W2795025443 via openalex
- W4386160360 via openalex
Source provenance
- europepmc
- last seen: 2026-11-20T06:18:20.042577+00:00
- openalex
- last seen: 2026-11-20T06:09:37.170340+00:00
- pubmed
- last seen: 2026-11-20T06:11:28.355738+00:00
- unpaywall
- last seen: 2026-11-20T08:37:33.920708+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine